Torres-Duque, Carlos A.
Ocampo-Gómez, Jaime
Castillo, Mauricio Morales
Cano-Rosales, Diana
Giraldo-Montoya, Ángela
Rodríguez, Freddy
Palacios-Ortega, Isabel
Durán-Silva, Mauricio
Reynales, Humberto
García, Elizabeth
Proaños-Jurado, Juliana
Carreño, Alejandro
Celis, Ana M.
Chapman, Edgardo
García, Maria B.
González-García, Mauricio
Jiménez-Maldonado, Libardo
Londoño, Julian
Morales, Edison
Morales-Castillo, Mauricio
Valencia, Viviana
Vanegas, Ingrid
Vargas-Ramírez, Leslie
,
Funding for this research was provided by:
Novartis de Colombia S.A.
Article History
Received: 6 April 2022
Accepted: 16 November 2022
First Online: 28 November 2022
Declarations
:
: This study (Protocol CIGE025BCO01 v3.0/October2019) was approved by the ethics committee of the coordinating center (Vita Ethics Committee, Chía, Colombia) as well as by the ethics committees of the participating centers in Colombia and their investigators (Centro Médico Imbanaco Ethics Committee, Fundación del Caribe para la Investigación Biomédica Ethics Committee, Fundación Neumológica Colombiana Ethics Committee, IPS Universitaria Ethics Committee, Instituto Neumológico del Oriente Ethics Committee) in accordance with the principles in the Declaration of Helsinki. Fundación Neumológica Ethics Committee requested an informed consent process to be performed with patients attending Fundación Neumológica Research Site, an informed consent form was designed an approved by this committee and applied with patients accordingly. All other participating sites obtained waivers to perform the informed consent process from their corresponding ethics committees, the list of ethics committees that provided waivers to apply an informed consent and the institution it was provided to are listed as follows: (1) Comité de Ética de Investigación del Centro Médico Imbanaco for Centro Médico Imbanaco. (2) Comité de Ética en la Investigación CAIMED for Centro de Atención e Investigación Médica CAIMED. (3) Comité de Ética en Investigación Biomédica del Instituto Neumológico del Oriente (CEINO) for Instituto Neumológico del Oriente (CEINO). (4) Comité de Ética e Investigación IPS Universitaria for IPS Universitaria. (5) Comité de Ética e Investigación IPS Universitaria for Unidad Alergológica. (6) Comité de Ética en la Investigación CAIMED for Unidad Médico Quirúrgica de ORL S.A.S. (7) Comité de Ética en la Investigación CAIMED for Ángela María Giraldo Montoya as Principal Investigator. (8) Comité de Ética en la Investigación CAIMED for Ángela María Giraldo Montoya as Principal Investigator. (9) Comité de Ética en la Investigación CAIMED for Elizabeth García as Principal Investigator.
: Not applicable.
: EG received funding from Novartis for the publication of this manuscript. JOG received funding from Novartis for the publication of this manuscript and has participated as speaker for the same company. MM currently works for Novartis de Colombia S.A. HR currently works as the executive director for CAIMED Chía.